Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-19

Clinical Trial Update: Sclerotherapy With Polidocanol Foam In The Treatment Of Hemorrhoidal Disease In Patients With Bleeding Disorders [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating sclerotherapy with polidocanol foam for hemorrhoidal disease in patients with bleeding disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Polidocanol foam (polidocanol)

Snippet

Sponsor: Universidade do Porto | Conditions: Hemorrhoids, Bleeding Disorder | Phase 2, Phase 3 | Status: UNKNOWN